Avalo Therapeutics (AVTX) Stock: Buy, Sell, or Hold?
AVTX - Avalo Therapeutics, Inc. Common Stock
$7.27
0.34 (4.91%)
â˛
5d:
-0.68%
30d:
-46.74%
90d:
-62.66%
WAIT
LOW Confidence
Analysis Updated: Nov 9, 2026 12:00 AM ET
Earnings: Nov 05, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 27, 2026 at $6.75 · last confirmed Nov 4, 2026
Strength: 7.5/10
Get Alerted When AVTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: AVTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: AVTX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: AVTX is currently trading at $7.27, which is considered slightly low relative to its 30-day fair value range of $7.18 to $13.36.
Technical Outlook: Technically, AVTX is in a strong downtrend. Immediate support is located at $6.53, while resistance sits at $7.71. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: AVTX scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $34.80 (+378.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AVTX is in a strong downtrend. Immediate support is located at $6.53, while resistance sits at $7.71. The stock is showing strong short-term momentum, up 4.9% recently.
Market Sentiment: AVTX scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $34.80 (+378.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$7.18 -
$13.36
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.9%)
- BULLISH: Trading 378.7% below Wall St target ($34.80)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.18 -
$13.36
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$6.53
Resistance Level
$7.71
Current Trend
Strong Downtrend
Technical data as of
Nov 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.82
Wall Street Target
$34.80
(+378.7%)
Revenue Growth (YoY)
-69.3%
Share AVTX Analysis
Share this live AVTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (AVTX)
Bullish
3 Retail Mentions
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Avalo Therapeutics ($AVTX) reported Q3 2026 financial results, announcing cash, cash equivalents, and investments of $462.8 million as of September 30, 2026.
Key Retail Themes:
Financial Results
Company Updates
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 09, 2026 10:04 PM ET
Data refreshes hourly during market hours. Next update: 11:04 PM
Data refreshes hourly during market hours. Next update: 11:04 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 47 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 50 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
18 analysts |
$72 | 28 SELL |
|
SNDX
Syndax Pharmaceuticals IâĻ |
STRONG BUY
12 analysts |
$35 | 50 HOLD |
More Analysis for AVTX
AVTX Technical Chart
AVTX Price Prediction
AVTX Earnings Date
Why is AVTX Moving Today?
AVTX Investment Advisor
AVTX Fair Price Analyzer
AVTX Competitors
AVTX DCF Intrinsic Value
Stock Sector Rotation Tracker
AI & Semi Supply Chain Money Flow
Live Gamma Exposure (GEX) Scanner
Reddit & WSB Sentiment Tracker
Backtested Stock Scanner
